Clinical Outcomes and Prognostic Factors of Salvage Stereotactic Body Radiotherapy for Post-Surgical Thoracic Oligo-Recurrence/Metastasis of Non-Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Clinical Outcomes and Prognostic Factors of Salvage Stereotactic Body Radiotherapy for Post-Surgical Thoracic Oligo-Recurrence/Metastasis of Non-Small-Cell Lung Cancer

Published:2021-02 Issue: Volume:Volume 13 Page:1887-1896
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Li Wen-Cai,Wang Zhen,Gao Jie,Zhou Han,Li Jing,Zhu Xi-Xu^ORCID

Publisher

Informa UK Limited

Subject

Oncology

Reference35 articles.

1. Predictors of Death, Local Recurrence, and Distant Metastasis in Completely Resected Pathological Stage-I Non–Small-Cell Lung Cancer

2. Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is ‘cured’ from postoperative recurrence?

3. Definitive Local Therapy for Oligo-recurrence in Patients With Completely Resected Non–small Cell Lung Cancer

4. Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic body radiotherapy for mediastinal lymph node with CyberKnife®: Efficacy and toxicity;Cancer/Radiothérapie;2023-05

2. Construction and Validation of a Recurrent Risk Nomogram Model for Non-Small Cell Lung Cancer within 1 Year after Radical Resection;Journal of Oncology;2022-07-19

3. Synthesis, Biological Activity, and Molecular Modelling Studies of Naphthoquinone Derivatives as Promising Anticancer Candidates Targeting COX-2;Pharmaceuticals;2022-04-27

4. Analysis of the clinical efficacy and safety of computerized tomography-guided 125 I seed implantation in the treatment of non-small cell lung cancer that relapsed after chemoradiotherapy;Journal of Cancer Research and Therapeutics;2022